Surface Oncology, Inc. Net Profit Margin 2018-2023 | SURF
Surface Oncology, Inc. net profit margin from 2018 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
Net Profit Margin Historical Data |
Date |
TTM Revenue |
TTM Net Income |
Net Margin |
2022-03-31 |
$0.03B |
$-0.06B |
-183.87% |
2021-12-31 |
$0.00B |
$-0.08B |
-2633.33% |
2021-09-30 |
$0.09B |
$0.01B |
13.19% |
2020-12-31 |
$0.13B |
$0.06B |
46.46% |
2020-03-31 |
$0.04B |
$-0.03B |
-71.79% |
2019-12-31 |
$0.01B |
$-0.06B |
-392.86% |
2019-09-30 |
$0.02B |
$-0.02B |
-70.83% |
2019-06-30 |
$0.03B |
$-0.02B |
-65.38% |
2019-03-31 |
$0.03B |
$-0.02B |
-53.57% |
2018-12-31 |
$0.06B |
$-0.01B |
-11.86% |
2018-09-30 |
$0.05B |
$-0.05B |
-88.24% |
2018-06-30 |
$0.05B |
$-0.04B |
-82.35% |
2018-03-31 |
$0.06B |
$-0.03B |
-60.00% |
2017-12-31 |
$0.01B |
$-0.05B |
-383.33% |